Iterum Therapeutics PLC (ITRM) — Strategic Asset Allocation Index
Iterum Therapeutics PLC (ITRM) has a Strategic Asset Allocation Index of 23.4% as of June 2023. Strategic assets (PP&E of $1.67 Million plus long-term investments of $-) total $1.67 Million, measured against net assets of $7.13 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Iterum Therapeutics PLC net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Iterum Therapeutics PLC Strategic Asset Allocation Index (2017–2022)
This chart shows how Iterum Therapeutics PLC's Strategic Asset Allocation Index has evolved across 4 annual periods from 2017 to 2022. As of June 2023, the index stands at 23.4%, representing strategic assets of $1.67 Million against net assets of $7.13 Million USD. For live market cap and overall valuation, see market value of Iterum Therapeutics PLC.
Annual Strategic Asset Allocation Index for Iterum Therapeutics PLC (2017–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Iterum Therapeutics PLC from 2017 to 2022, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Iterum Therapeutics PLC net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 6.6% | $1.84 Million | $1.84 Million | $- | $28.00 Million | ▲ +6.4 pp |
| 2021 | 0.2% | $91.00K | $91.00K | $- | $50.23 Million | ▼ -0.8 pp |
| 2018 | 1.0% | $700.00K | $700.00K | $- | $71.62 Million | ▼ -0.9 pp |
| 2017 | 1.9% | $747.00K | $747.00K | $- | $39.49 Million | — |